Grants and Contracts Details
Description
HUMAN CLINICAL TRIAL - CONFIDENTIAL
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia in a Very High Risk Stratum
STUDY: AALL1131 – SANOFI/GENZYME
A study drug – Clofarabine (Ind #73789, NSC #606869) also known as Clolar® (US); clinical
material as described further in the Protocol, which is a proprietary drug of the
Funding Entity.
| Status | Finished |
|---|---|
| Effective start/end date | 9/23/15 → 10/10/19 |
Funding
- Childrens Hospital of Philadelphia: $4,666.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.